Atara Biotherapeutics (ATRA) Inventory (2022 - 2024)

Atara Biotherapeutics' Inventory history runs 3 years deep, the most recent figure standing at $10.7 million for Q4 2024.

• Quarterly Inventory rose 9.78% year-over-year to $10.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $10.7 million (up 9.78% YoY) and the FY2024 annual result came in at $10.7 million, up 9.78% from the prior year.
• Inventory was $10.7 million for Q4 2024 at Atara Biotherapeutics, down from $14.0 million in the prior quarter.
• Across five years, Inventory topped out at $18.7 million in Q2 2024 and bottomed at $1.6 million in Q4 2022.
• A 3-year average of $10.1 million and a median of $9.7 million in 2023 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory soared 511.98% — and 2024, when it climbed 9.78%.
• Atara Biotherapeutics' Inventory stood at $1.6 million in 2022, then surged by 511.98% to $9.7 million in 2023, then climbed by 9.78% to $10.7 million in 2024.
• Business Quant data shows ATRA's Inventory at $10.7 million in Q4 2024, $14.0 million in Q3 2024, and $18.7 million in Q2 2024.